The ILLUMINATE-101 clinical research study is evaluating the safety and effectiveness of an investigational medication designed to reduce or eliminate the negative immune response to gluten in adults with celiac disease and participants are needed.   Benefits Include:               ✅ Possible compensation for time + travel             ✅ Study-related care at no cost             ✅ Helping progress celiac research